European Drug Safety & AI 2026

24–25 Feb 2026 | Barcelona, Spain

Tuesday, 24 February 2026 | 15:50 - 16:50

PANEL DISCUSSION: RESPONSIBLE AI IN PRACTICE: OVERSIGHT, TRANSPARENCY, AND REGULATORY ACCOUNTABILITY

Location:Gloria B, C, D
  • Regulatory uncertainty: difficulty in designing AI systems that are simultaneously innovative, compliant, and inspection-proof across regions. 

  • Accountability vs automation: under-using AI to avoid perceived liability, limiting its value 

  • Data bias and representativeness 

  • End-to-end transparency 

  • Data protection 

  • Governance gaps between functions

3 speakers

  • Head of International Medical Affairs

    FAES Farma

  • Technical and Regulatory Affairs Director

    Italfarmco

  • Director, European Data Protection Officer - EU/EEA, UK and Switzerland

    Bristol Myers Squibb

Location image

Session location Gloria B, C, D